	US 12,202,907 B2
	Nucleic acids encoding and methods of producing proteins comprising antibody chains
Stéphanie Chanteux, Marseilles (FR); Laurent Gauthier, Marseilles (FR); Nicolas Gourdin, Marseilles (FR); Carine Paturel, Marcy I'Etoile (FR); Ivan Perrot, Cassis (FR); and Benjamin Rossi, Marseilles (FR)
Assigned to Innate Pharma, Marseilles (FR); and Orega Biotech, Ecully (FR)
Filed by Innate Pharma, Marseilles (FR); and Orega Biotech, Ecully (FR)
Filed on Jun. 30, 2022, as Appl. No. 17/855,510.
Application 17/855,510 is a division of application No. 16/443,744, filed on Jun. 17, 2019, granted, now 11,377,503.
Claims priority of provisional application 62/686,165, filed on Jun. 18, 2018.
Prior Publication US 2023/0025732 A1, Jan. 26, 2023
Int. Cl. C07K 16/28 (2006.01); A61P 35/00 (2006.01); G01N 33/574 (2006.01)

CPC C07K 16/2896 (2013.01) [A61P 35/00 (2018.01); G01N 33/57492 (2013.01); C07K 2317/24 (2013.01); C07K 2317/33 (2013.01); C07K 2317/41 (2013.01); C07K 2317/52 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); C07K 2317/74 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01)]

36 Claims

1. A nucleic acid encoding a protein comprising a heavy chain variable region comprising the amino acid sequence of SEQ ID NO: 31 and/or a protein comprising a light chain variable region comprising the amino acid sequence of SEQ ID NOS: 36 or 37.